STOCK TITAN

Amarin Announces Two Upcoming Investor Events

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

Amarin plc (NASDAQ:AMRN) has announced two upcoming investor events. The first event is the Third Quarter 2024 Financial Results report on October 30, 2024, followed by a conference call with senior management at 5:00 pm ET. Investors can access the live call through the company's website or by dialing in.

The second event is a Virtual Analyst & Investor Day on November 14, 2024, from 8:00 AM to 10:00 AM EST. This event will focus on updating the investment community about the VASCEPA/VAZKEPA franchise, with emphasis on key geographies representing the franchise's future value, including Europe. The event will include a Q&A session with questions submitted in advance. Both events will be webcast and archived for future reference.

Amarin plc (NASDAQ:AMRN) ha annunciato due eventi imminenti per gli investitori. Il primo evento è il report sui Risultati Finanziari del Terzo Trimestre 2024, che si terrà il 30 ottobre 2024, seguito da una conferenza telefonica con il senior management alle 17:00 ET. Gli investitori possono accedere alla chiamata dal vivo tramite il sito web dell'azienda o componendo il numero.

Il secondo evento è un Giorno Virtuale per Analisti e Investitori che si svolgerà il 14 novembre 2024, dalle 8:00 alle 10:00 EST. Questo evento si concentrerà sull'aggiornamento della comunità degli investimenti riguardo il franchise VASCEPA/VAZKEPA, con enfasi sulle principali aree geografiche che rappresentano il futuro valore del franchise, incluso l'Europa. L'evento includerà una sessione di domande e risposte con domande da presentare in anticipo. Entrambi gli eventi saranno trasmessi in webcast e archiviati per riferimento futuro.

Amarin plc (NASDAQ:AMRN) ha anunciado dos próximos eventos para inversores. El primer evento es el informe de Resultados Financieros del Tercer Trimestre 2024 el 30 de octubre de 2024, seguido de una llamada de conferencia con la alta dirección a las 5:00 p.m. ET. Los inversores pueden acceder a la llamada en vivo a través del sitio web de la empresa o marcando el número correspondiente.

El segundo evento es un Día Virtual para Analistas e Inversores el 14 de noviembre de 2024, de 8:00 AM a 10:00 AM EST. Este evento se centrará en actualizar a la comunidad inversora sobre el franchise de VASCEPA/VAZKEPA, haciendo hincapié en las principales geografías que representan el valor futuro del franchise, incluyendo Europa. El evento incluirá una sesión de preguntas y respuestas con preguntas enviadas por adelantado. Ambos eventos se transmitirán por webcast y se archivarán para referencia futura.

아마린 plc (NASDAQ:AMRN)가 두 가지 예정된 투자자 이벤트를 발표했습니다. 첫 번째 이벤트는 2024년 3분기 재무 결과 보고서로, 2024년 10월 30일에 발표됩니다. 이후 고위 경영진과의 컨퍼런스 콜이 오후 5시에 진행됩니다. 투자자들은 회사 웹사이트를 통해 라이브 콜에 접속하거나 전화를 통해 참여할 수 있습니다.

두 번째 이벤트는 가상 애널리스트 및 투자자 데이로, 2024년 11월 14일 오전 8시부터 10시까지 EST에 진행됩니다. 이 이벤트는 VASCEPA/VAZKEPA 프랜차이즈에 대한 최신 정보를 투자자들에게 제공하는 데 중점을 두며, 프랜차이즈의 미래 가치를 나타내는 주요 지역에 대한 강조가 포함됩니다. 이벤트에는 사전 제출된 질문을 포함한 Q&A 세션이 포함됩니다. 두 이벤트 모두 웹캐스트로 방송되며 향후 참고를 위해 아카이브됩니다.

Amarin plc (NASDAQ:AMRN) a annoncé deux événements à venir pour les investisseurs. Le premier événement est le rapport sur les Résultats Financiers du Troisième Trimestre 2024 prévu le 30 octobre 2024, suivi d'une conférence téléphonique avec la direction à 17h00 ET. Les investisseurs peuvent accéder à l'appel en direct via le site web de l'entreprise ou en composant le numéro.

Le deuxième événement est une Journée Virtuelle pour les Analystes et les Investisseurs le 14 novembre 2024, de 8h00 à 10h00 EST. Cet événement se concentrera sur la mise à jour de la communauté des investisseurs concernant le secteur VASCEPA/VAZKEPA, avec un accent sur les principales géographies représentant la valeur future du secteur, y compris l'Europe. L'événement comprendra une session de questions-réponses avec des questions soumises à l'avance. Les deux événements seront diffusés en webcast et archivés pour une référence future.

Amarin plc (NASDAQ:AMRN) hat zwei bevorstehende Investorenveranstaltungen angekündigt. Die erste Veranstaltung ist der Bericht über die Finanzergebnisse des dritten Quartals 2024, der am 30. Oktober 2024 veröffentlicht wird, gefolgt von einer Telefonkonferenz mit der Geschäftsführung um 17:00 Uhr ET. Investoren können auf den Live-Call über die Website des Unternehmens zugreifen oder sich einwählen.

Die zweite Veranstaltung ist ein Virtueller Analysten- und Investoren-Tag am 14. November 2024 von 8:00 bis 10:00 Uhr EST. Diese Veranstaltung wird sich darauf konzentrieren, die Investoren-Community über das VASCEPA/VAZKEPA-Franchise zu informieren, mit einem Schwerpunkt auf den wichtigsten geografischen Regionen, die den zukünftigen Wert des Franchises darstellen, einschließlich Europa. Die Veranstaltung umfasst eine Q&A-Session, in der Fragen im Voraus eingereicht werden können. Beide Veranstaltungen werden per Webcast übertragen und für zukünftige Nachweise archiviert.

Positive
  • None.
Negative
  • None.

-- Company to Report Third Quarter 2024 Financial Results Wednesday, October 30 –-

-- Amarin to Hold Virtual Analyst & Investor Day Thursday, November 14 --

DUBLIN and BRIDGEWATER, N.J., Oct. 01, 2024 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced two important near-term corporate events:

[I] Third Quarter 2024 Financial Results – October 30 – The Company will report financial results for the third quarter 2024 on Wednesday, October 30, 2024, immediately following the close of market trading followed by a conference call with Amarin’s senior management team at 5:00 pm ET.

Conference Call and Webcast Information:

Access to the live call:
Go to the investor relations section of the Company's website at www.amarincorp.com
Dial in within the United States: 888-506-0062
International dial in: 973-528-0011
Access Code: 732244

Access to replay: 
Dial in within the United States: 877-481-4010 
International dial in: 919-882-2331
Access Code: 51361

A replay of the call will also be available through the Company's website shortly after the call. 

[II] Virtual Analyst & Investor Day 2024 – November 14 – The Company will host a virtual analyst and investor day on Thursday, November 14, 2024, from 8:00 AM EST to 10:00 AM EST. The event will be hosted by members of the Amarin senior management team and will focus on updating the investment community on the current state of the VASCEPA/VAZKEPA franchise, with particular attention given to discussions on the dynamics of key geographies that represent the future value of the franchise, including Europe. In addition, a dedicated question and answer session will be held during which the Amarin senior management team will entertain questions submitted in advance to investor.relations@amarincorp.com.

As a virtual event, the program will be webcast and archived for future reference and will be open to all participants; participation will require a simple registration step before joining, which will be available through the Company website prior to this event. Throughout the event, there will be no live interaction with audience participants.

About Amarin
Amarin is an innovative pharmaceutical company leading a new paradigm in cardiovascular disease management. Amarin has offices in Bridgewater, New Jersey in the United States, Dublin in Ireland, Zug in Switzerland, and other countries in Europe as well as commercial partners and suppliers around the world. We are committed to increasing the scientific understanding of the cardiovascular risk that persists beyond traditional therapies and advancing the treatment of that risk.

Availability of Other Information About Amarin 
Amarin communicates with its investors and the public using the company website (www.amarincorp.com) and the investor relations website (http://www.amarincorp.com/investor-relations), including but not limited to investor presentations and FAQs, Securities and Exchange Commission filings, press releases, public conference calls and webcasts. The information that Amarin posts on these channels and websites could be deemed to be material information. As a result, Amarin encourages investors, the media and others interested in Amarin to review the information that is posted on these channels, including the investor relations website, on a regular basis. This list of channels may be updated from time to time on Amarin’s investor relations website and may include social media channels. The contents of Amarin’s website or these channels, or any other website that may be accessed from its website or these channels, shall not be deemed incorporated by reference in any filing under the Securities Act of 1933. 

Amarin Contact Information
Investor & Media Inquiries:
Mark Marmur
Amarin Corporation plc
PR@amarincorp.com
Investor.relations@amarincorp.com


FAQ

When will Amarin (AMRN) report its Q3 2024 financial results?

Amarin (AMRN) will report its third quarter 2024 financial results on Wednesday, October 30, 2024, immediately after market close.

What is the date and time of Amarin's (AMRN) Virtual Analyst & Investor Day 2024?

Amarin's (AMRN) Virtual Analyst & Investor Day 2024 is scheduled for Thursday, November 14, 2024, from 8:00 AM to 10:00 AM EST.

What will be the focus of Amarin's (AMRN) Virtual Analyst & Investor Day 2024?

The event will focus on updating the investment community on the current state of the VASCEPA/VAZKEPA franchise, particularly discussing the dynamics of key geographies representing the franchise's future value, including Europe.

How can investors participate in Amarin's (AMRN) Q3 2024 earnings call?

Investors can participate in Amarin's (AMRN) Q3 2024 earnings call by accessing the investor relations section of the company's website or by dialing in using the provided U.S. and international phone numbers.

Will there be a Q&A session during Amarin's (AMRN) Virtual Analyst & Investor Day 2024?

Yes, there will be a dedicated Q&A session during Amarin's (AMRN) Virtual Analyst & Investor Day 2024, where management will address questions submitted in advance to investor.relations@amarincorp.com.

Amarin Corp Plc

NASDAQ:AMRN

AMRN Rankings

AMRN Latest News

AMRN Stock Data

191.60M
404.75M
1.6%
17.05%
4.36%
Drug Manufacturers - General
Pharmaceutical Preparations
Link
United States of America
DUBLIN 2